Inventor
BERG STEFAN
SE39 patents
⚠️ This page may combine multiple inventors who share the name “BERG STEFAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTRAZENECA AB
25 patentsUS6479497B1Nov 12, 2002
Substituted chroman derivatives
ASTRAZENECA AB16 citations92
US6159971ADec 12, 2000
Combination of a 5-HT reuptake inhibitor and a h5-HT1B anatagonist or partial agonist
ASTRAZENECA AB26 citations92
US6387899B1May 14, 2002
Substituted chroman derivatives
ASTRAZENECA AB18 citations90
US7595319B2Sep 29, 2009
Compounds having selective inhibiting effect at GSK3
ASTRAZENECA AB15 citations83
US7585853B2Sep 8, 2009
Compounds having selective inhibiting effect at GSK3
ASTRAZENECA AB9 citations83
US7342022B2Mar 11, 2008
Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3
ASTRAZENECA AB9 citations82
US7399780B2Jul 15, 2008
3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3
ASTRAZENECA AB12 citations81
US7205314B2Apr 17, 2007
Compounds for the treatment of dementia related diseases
ASTRAZENECA AB12 citations80
US6159970ADec 12, 2000
Combination of a monoamine oxidase inhibitor and a h5-HT1B antagonist or partial agonist
ASTRAZENECA AB7 citations73
US7855213B2Dec 21, 2010
Compounds
ASTRAZENECA AB7 citations71
US6384225B1May 7, 2002
Intermediates in the preparation of substituted chroman derivatives
ASTRAZENECA AB7 citations71
US7595321B2Sep 29, 2009
Compounds having selective inhibiting effect at GSK3
ASTRAZENECA AB4 citations62
US7056939B2Jun 6, 2006
4-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3 (gsk3)
ASTRAZENECA AB4 citations62
US6291458B1Sep 18, 2001
Morpholinobenzamide salts
ASTRAZENECA AB3 citations62
US6159972ADec 12, 2000
Combination of a selective 5-HT1A antagonist and a selective ub. h5-HT.s1B antagonist or partial agonist
ASTRAZENECA AB6 citations62
US7078410B2Jul 18, 2006
2-arylamino-pyrimidines for the treatment of GSK3-related disorders
ASTRAZENECA AB7 citations61
US6548498B1Apr 15, 2003
Substituted indan derivatives
ASTRAZENECA AB2 citations61
US6534652B2Mar 18, 2003
Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivatives
ASTRAZENECA AB0 citations52
US6410532B2Jun 25, 2002
Substituted 1,2,3,4-tetrahydronaphthalene derivatives
ASTRAZENECA AB0 citations52
US7683067B2Mar 23, 2010
3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3)
ASTRAZENECA AB1 citations51
US7384943B2Jun 10, 2008
Substituted chroman derivatives
ASTRAZENECA AB0 citations51
US7345050B2Mar 18, 2008
Pyrimidine compounds
ASTRAZENECA AB1 citations51
US6670359B2Dec 30, 2003
Substituted chroman derivatives
ASTRAZENECA AB0 citations51
US7439356B2Oct 21, 2008
Substituted indan derivatives
ASTRAZENECA AB0 citations50
US6410530B1Jun 25, 2002
Substituted 1,2,3,4-tetrahydronaphthalene derivatives
ASTRAZENECA AB1 citations50
ELEIKO GROUP AB
4 patentsUSD1043874SSep 24, 2024
Part of exercising equipment
ELEIKO GROUP AB3 citations66
US12005316B2Jun 11, 2024
Barbell with integrated sensor
ELEIKO GROUP AB0 citations52
US11135471B2Oct 5, 2021
Barbell rack with tilt function
ELEIKO GROUP AB0 citations52
US12233304B2Feb 25, 2025
Weightlifting disc with a reinforcement device
ELEIKO GROUP AB0 citations47